Christa Pawlowski, PhD
Christa Pawlowski has 10 years of research experience related to life sciences and drug development. While focused on cardiovascular disorders, her experience also includes inflammation, immune response and cancer. Prior to joining Allinaire, Dr. Pawlowski was a Postdoctoral Scholar at Case Western Reserve University and co-founder of Haima Therapeutics LLC, a biotechnology company focused on the translation of a novel synthetic platelet nanotechnology for the treatment of hemorrhage after traumatic injury.
Dr. Pawlowski received her PhD in Biomedical Engineering from Case Western Reserve University